CION Ameerpet
Medically reviewed by Dr. Muralidhar Muddusetty, MBBS (AIIMS), MS Surgery (AIIMS), DNB Surgical Oncology, MRCS (Edinburgh) — Senior Surgical Oncologist, CION Cancer Clinics · Last reviewed June 2026
A sentinel lymph node biopsy checks the very first lymph node your breast tumour would drain into, to see whether cancer has begun to spread. By sampling just one or a few nodes instead of clearing the whole underarm, it gives an accurate answer while sparing most women the swelling, stiffness and lifelong arm care that full axillary clearance can bring. At CION Cancer Clinics in Hyderabad, sentinel node biopsy is the standard first step for early, node-negative breast cancer — planned by our tumor board, with a free first consultation.
Lymph fluid drains away from the breast in an orderly way, and the sentinel lymph node is the very first node that fluid from a breast tumour reaches — usually in the underarm (axilla). Because it is first in line, it is the node where breast cancer cells would most likely turn up first if they had begun to travel. Checking it tells us, with high accuracy, whether the cancer has started to spread to the lymph nodes — one of the most important pieces of information for staging and planning treatment.
This matters because the lymph node result changes everything that follows: the stage of the cancer, whether chemotherapy or radiation is advised, and the type of surgery. Imaging and a clinical exam are not enough on their own — studies show that a meaningful share of women whose nodes look normal on scans still have microscopic cancer in them. The only reliable way to know is to remove and examine the sentinel node itself.
The key idea is elegant and kind to the patient: instead of removing every node in the armpit just to find out, we find and test the one node that matters most. If that first node is clear, the nodes beyond it are very likely clear too — so most women can be spared a much bigger operation. At CION, this principle guides how we stage the axilla for early breast cancer.
The sentinel node is the first the breast tumour drains into, so it is where spread shows up first.
Whether the node has cancer decides the stage and shapes chemo, radiation and surgery choices.
Some women with normal-looking nodes still have microscopic cancer — only sampling the node confirms it.
A large Indian tertiary-centre study found the sentinel node was correctly identified about 98% of the time with the dual dye method versus 94% with blue dye alone, with a false-negative rate under 1%. Source: Tata Medical Center, India (PMC9300403).
How it works
The procedure is built around mapping — using a tracer that travels the exact path lymph fluid would take, so the surgeon can pinpoint the true sentinel node rather than guess. A small amount of tracer is injected near the tumour or around the nipple before or during surgery, and it flows into the first draining node, marking it. The biopsy is usually done under general anaesthesia, often at the same time as the breast surgery, and most women go home the same day or the next morning. Surgeons use one or, ideally, two tracers together — the dual technique finds the sentinel node more reliably than dye alone (about 98% versus 94%), and the technique at CION is chosen for accuracy and tailored to each patient.
A small, safe dose of radioactive tracer is injected before surgery and detected with a handheld gamma probe in theatre. The radioactivity is very low and clears from the body within a day or two, mostly in the urine. It is the most established mapping agent and underpins lymphoscintigraphy imaging where used.
A blue dye injected near the tumour travels through the lymphatics and visibly stains the sentinel node, which the surgeon follows by eye through a small incision. It is inexpensive and widely available, which matters in Indian practice, but works best when paired with a second tracer because dye alone has a slightly lower identification rate.
ICG is a fluorescent dye seen with a near-infrared camera; it lights up the sentinel node and lymphatic channels in real time. It is an increasingly popular, radiation-free alternative in India and other resource-conscious settings, giving identification rates close to the radioisotope while avoiding the need for a nuclear-medicine facility.
Combining two tracers — typically dye plus isotope or ICG — raises the chance of finding the true sentinel node to around 98% and lowers the false-negative rate. Most modern guidelines and CION's surgical team favour a dual approach wherever feasible, because correctly identifying the first node is what makes the whole result trustworthy.
Guided by the probe or the dye/fluorescence, the surgeon makes a small incision in the underarm and removes the node or nodes that are hot, blue or fluorescent. Studies suggest removing roughly one to three sentinel nodes is usually enough; taking more than about four rarely adds information and adds risk.
The removed nodes go to a pathologist. Some centres do a rapid frozen-section check during the operation so a decision can be made immediately; others wait for the more detailed final report over a few days. CION explains in advance which approach applies to you and what each result would mean for your next step.
For decades, the standard was axillary lymph node dissection (ALND) — removing most or all of the underarm nodes to stage and treat the cancer. It worked, but it came at a cost: removing so many nodes disrupts lymph drainage from the arm, leading to a real risk of lymphedema (long-term arm swelling), shoulder stiffness, numbness and a condition called cording. These can be lifelong and need careful arm care for years.
Sentinel node biopsy changed this. Landmark trials — including the ACOSOG Z0011 study — showed that for many women with early, clinically node-negative breast cancer, sampling just the sentinel node is as safe as clearing the whole axilla, with the same survival and very low recurrence, but far fewer side effects. The difference in arm swelling is striking: lymphedema occurs in only about 0.5-3% of women after sentinel node biopsy, compared with roughly 5-17% after full axillary dissection. That is why, today, sentinel node biopsy is the recommended first approach for the right patients — and full clearance is reserved for those who genuinely need it.
About 0.5-3% arm-swelling risk after sentinel biopsy versus roughly 5-17% after full axillary clearance.
For early node-negative cancer, sampling the sentinel node matches full dissection on survival and recurrence.
A smaller incision and fewer nodes removed mean less shoulder restriction, cording and nerve disturbance.
Once the sentinel node is examined, the result falls into one of two camps — and understanding what each means takes a lot of the fear out of waiting. In roughly 70-80% of early breast cancers the sentinel node is negative, which is reassuring news. A positive result is not a disaster either; it simply guides the next, well-established step. Either way, your tumor board uses the result to build the safest plan for you.
A negative sentinel node means no cancer cells were found in the first draining node, so it is very unlikely the cancer has spread further along the chain. In most cases, no more underarm nodes need to be removed — you avoid a bigger operation and its side effects. A positive sentinel node means cancer cells were found. Importantly, this no longer automatically means full axillary clearance: thanks to Z0011 and later evidence, many women with only one or two positive sentinel nodes who are having breast-conserving surgery and radiation can safely skip further node surgery. When more nodes are involved, completion axillary dissection or axillary radiation may be advised. CION decides this at the tumor board, never by a single rule.
No cancer in the first node — spread is unlikely, and usually no further node surgery is needed.
With one to two positive nodes plus breast-conserving surgery and radiation, many women can safely avoid full clearance.
How many nodes are involved, your surgery type and other features decide the next step — agreed by the tumor board.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Free first consultation. Confidential, doctor-led guidance at CION Cancer Clinics, Hyderabad. Call us: 1800-202-8726.
One of the biggest advantages of a sentinel node biopsy is how much gentler recovery is than after full axillary clearance. The incision is small, and most women go home the same day or the next morning. You can expect some soreness, bruising and a little swelling in the underarm for a couple of weeks, and the blue dye (if used) can tint your skin and urine for a day or two — this is harmless and fades on its own. Most everyday activities return within a few days, with heavier lifting and exercise resumed gradually over a few weeks.
Because some lymph drainage is still disturbed, sensible arm care lowers your already-low lymphedema risk further and helps the shoulder stay supple. The steps below are simple and lifelong-friendly rather than restrictive. CION's nursing team teaches them before you go home, and our physiotherapists guide gentle shoulder exercises so movement returns fully. Always tell us promptly if the arm swells, feels tight, or the wound looks red or hot.
The small incision means most women recover at home quickly, with light activity in a few days and a gradual return to exercise over two to three weeks.
Starting easy, guided shoulder and arm movements within the first days prevents stiffness and cording. CION's physiotherapy team shows you exactly what to do and when to progress.
Avoid cuts, burns and insect bites on the operated side, keep the skin moisturised, and treat any small wound promptly — minor skin breaks are the commonest trigger for arm swelling after node surgery.
Tell your team early if the hand, forearm or upper arm feels heavy, tight or looks larger — early lymphedema is far easier to control, and the overall risk after sentinel biopsy is low to begin with.
Keep the incision clean and dry as instructed, and contact us for fever, spreading redness, increasing pain or fluid build-up (seroma). These are uncommon and usually settle quickly when caught early.
At CION Cancer Clinics, sentinel lymph node biopsy is the standard, default approach for staging the axilla in early, clinically node-negative breast cancer — not an add-on you have to ask for. Our surgical oncologists use a dual mapping technique wherever feasible to maximise accuracy, and we keep full axillary clearance for the patients who genuinely need it. This reflects current international guidance (NCCN, ASCO) and the Z0011 evidence, applied thoughtfully to each woman rather than as a blanket rule.
What sets the CION pathway apart is that the axillary decision is never one surgeon's call. Every breast cancer case is reviewed by our tumor board — surgical, medical and radiation oncologists together — so the choice between sentinel biopsy alone, axillary radiation or completion dissection is made on the full picture of your cancer. We are a woman-headed organisation, transparent on cost, and committed to no unnecessary tests and no rushed decisions. The aim is the least surgery that gives the safest answer.
Sentinel biopsy is our standard first step for node-negative disease, with dual mapping for accuracy.
Surgical, medical and radiation oncologists agree your node plan together — never one opinion.
Full clearance is reserved for those who truly need it, sparing most women avoidable side effects.
Facing breast surgery is daunting, so CION built a pathway that is calm, transparent and team-led from the first appointment. Every consultation runs a full 45 minutes — time to understand your diagnosis, see your options laid out honestly, and ask everything you need to. Your case is reviewed by our tumor board before any operation, so the plan for your breast and your underarm nodes is agreed by specialists together, with clear, upfront costs and no unnecessary tests.
With 150+ years of combined oncology experience, 17 super-specialist oncologists and 35+ centres across Telangana and AP, we have guided more than 15,000 patients — earning a 4.8/5 Google rating across our centres. For breast cancer, CION's outcomes lead the national average: a 96.9% one-year survival rate at CION versus 85.4% nationally*. Whether you are newly diagnosed or seeking a second opinion on your surgery plan, your first consultation is free.
*1-year survival. Source: ICMR / National Cancer Registry Programme (NCRP).
No rushed decisions, no unnecessary tests — decisions for healing, not billing.
Surgical, medical and radiation oncologists review your case together before any surgery.
A clear estimate in advance — including diagnostics — with no hidden charges.
Newly diagnosed or seeking a second opinion, your first appointment at CION is free.
Hear from women treated for early breast cancer at CION who avoided bigger surgery thanks to a sentinel node biopsy.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.A sentinel lymph node biopsy is surgery to find, remove and examine the first lymph node (or few nodes) that a breast tumour would drain into — usually in the underarm. Because it is first in the drainage path, it is where cancer cells would most likely appear first if the cancer had begun to spread. Checking it tells your team, with high accuracy, whether cancer has reached the lymph nodes — a key part of staging. The clever part is that instead of removing every node just to find out, the surgeon tests only the node that matters most. If it is clear, the nodes beyond it are very likely clear too, so most women avoid a much bigger operation.
Before or during surgery, a tracer is injected near the tumour or around the nipple. It travels the same path lymph fluid would, marking the sentinel node so the surgeon can find it. Surgeons use a blue dye, a radioactive isotope, indocyanine green fluorescence, or — ideally — a combination of two of these, because the dual technique finds the right node most reliably (around 98% versus about 94% for dye alone). Guided by a gamma probe or by the dye/fluorescence, the surgeon removes one to three marked nodes through a small underarm incision, usually under general anaesthesia and often during the breast surgery itself. A pathologist then examines the nodes for cancer cells.
For decades the standard was axillary lymph node dissection — removing most underarm nodes. It staged the cancer well but disrupted lymph drainage from the arm, causing a real risk of lymphedema (long-term arm swelling), stiffness, numbness and cording. Landmark trials, including ACOSOG Z0011, showed that for many women with early, clinically node-negative breast cancer, sampling just the sentinel node is as safe as full clearance — same survival and very low recurrence — with far fewer side effects. Arm swelling occurs in only about 0.5-3% after sentinel biopsy versus roughly 5-17% after full dissection. That is why sentinel node biopsy is now the recommended first approach, with full clearance kept for those who truly need it.
A negative sentinel node — the result in about 70-80% of early breast cancers — means no cancer cells were found in the first draining node, so spread further along the chain is very unlikely and usually no more nodes need to be removed. A positive sentinel node means cancer cells were found, but this no longer automatically means full axillary clearance. Thanks to the Z0011 evidence and later studies, many women with only one or two positive sentinel nodes who are having breast-conserving surgery and radiation can safely avoid further node surgery. When more nodes are involved, completion dissection or axillary radiation may be advised. At CION the next step is always decided by the tumor board, never by a single rule.
The risk is low — much lower than after full axillary clearance. Lymphedema (lasting arm swelling) occurs in only about 0.5-3% of women after a sentinel node biopsy, compared with roughly 5-17% after axillary lymph node dissection, because far fewer nodes are removed and lymph drainage is largely preserved. You can lower the risk further with simple arm care: protect the operated side from cuts, burns and insect bites, keep the skin moisturised, do the gentle shoulder exercises your physiotherapist teaches, and report any heaviness, tightness or swelling early. Caught early, swelling is far easier to control. CION's nursing and physiotherapy teams guide you through all of this before you go home.
Recovery is gentle compared with bigger node surgery. The incision is small, and most women go home the same day or the next morning. Expect some soreness, bruising and mild underarm swelling for a couple of weeks; if blue dye was used, your skin and urine may be tinted for a day or two, which is harmless. Most everyday activities return within a few days, with heavier lifting and exercise resumed gradually over two to three weeks. Gentle, guided shoulder exercises help prevent stiffness. Contact your team promptly for fever, spreading redness, increasing pain, or fluid build-up (seroma) — these are uncommon and usually settle quickly when caught early.
Sentinel node biopsy is the standard approach for early breast cancer where the underarm nodes look and feel normal (clinically node-negative) on examination and scans. It is generally not the first choice when there is already obvious, bulky cancer in the underarm nodes, where full clearance may be needed instead. Whether it suits you depends on your tumour, your scans, whether you are having chemotherapy before surgery, and your overall plan. At CION, our tumor board reviews these details together and explains clearly whether a sentinel node biopsy, axillary radiation or a fuller dissection is right for your case — so the decision is informed, individualised and made with you.
Start with a free first consultation — book online or call CION at 1800-202-8726. Your first appointment is an unhurried, 45-minute conversation that reviews your diagnosis and scans and lays out your surgical options clearly. If a sentinel node biopsy is part of your plan, we explain exactly how it will be done, what each result would mean, and the costs involved — including any diagnostics — with a transparent estimate in advance and no unnecessary tests. Every breast cancer case is reviewed by our tumor board, so your surgery plan is genuinely personalised. Whether you are newly diagnosed or seeking a second opinion, the first consultation is free.